The Cdk5 inhibitor olomoucine promotes corneal debridement wound closure in vivo

Molecular Vision

Volumn 14, Issue , 2008, Pages 542-549

  Tripathi, Brajendra K ^a   Stepp, Mary A ^b   Gao, Chun Y ^a   Zelenka, Peggy S ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; DIMETHYL SULFOXIDE; DYE; ERYTHROMYCIN; GELATINASE A; GELATINASE B; OLOMOUCINE; PARAFFIN;

ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORNEA INJURY; CORNEA LIMBUS; DEBRIDEMENT; EPITHELIUM CELL; EYE PHOTOGRAPHY; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MOUSE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SINGLE DRUG DOSE; WOUND CLOSURE; WOUND HEALING;

ANIMALS; CADHERINS; CELLS, CULTURED; CORNEA; CYCLIN-DEPENDENT KINASE 5; DEBRIDEMENT; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; KINETIN; LIMBUS CORNEAE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED STRAINS; NEUTROPHILS; TIME FACTORS; TISSUE DISTRIBUTION; WOUND HEALING;

EID: 41549122844     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wilson SE, Mohan RR, Mohan RR, Ambrosio R Jr, Hong J, Lee J. The corneal wound heating response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res 2001; 20:625-37.
2. Gao CY, Stepp MA, Fariss R, Zelenka P. Cdk5 regulates activation and localization of Src during corneal epithelial wound closure. J Cell Sci 2004; 117:4089-98.
3. Frame MC. Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 2004; 117:989-98.
4. D'Souza-Schorey C. Disassembling adherens junctions: breaking up is hard to do. Trends Cell Biol 2005; 15:19-26.
5. Avizienyte E, Fincham VJ, Brunton VG, Frame MC. Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition. Mol Biol Cell 2004; 15:2794-803.
6. Zelena PS, Smith J. Therapeutic potential of CDK5 inhibitors to promote corneal epithelial wound healing. Expert Opin Therap Patents 2005; 15:875-87.
7. Pal-Ghosh S, Pajoohesh-Ganji A, Brown M, Stepp MA. A mouse model for the study of recurrent corneal epithelial erosions: alpha9beta1 integrin implicated in progression of the disease. Invest Ophthalmol Vis Sci 2004; 45:1775-88.
8. Ledee DR, Gao CY, Seth R, Fariss RN, Tripathi BK, Zelenka PS. A specific interaction between muskelin and the cyclin-dependent kinase 5 activator p39 promotes peripheral localization of muskelin. J Biol Chem 2005; 280:21376-83.
9. Pajoohesh-Ganji A, Ghosh SP, Stepp MA. Regional distribution of alpha9beta1 integrin within the limbus of the mouse ocular surface. Dev Dyn 2004; 230:518-28.
10. Gao C, Negash S, Guo HT, Ledee D, Wang HS, Zelenka P. CDK5 regulates cell adhesion and migration in corneal epithelial cells. Mol Cancer Res 2002; 1:12-24.
11. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002; 21:1-14.
12. Matsubara M, Girard MT, Kublin CL. Cintron C, Fini ME. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol 1991; 147:425-39.
13. Schang LM. Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother 2002; 50:779-92.
14. Hanna C. Proliferation and migration of epithelial cells during corneal wound repair in the rabbit and the rat. Am J Ophthalmol 1966; 61:55-63.
15. Stepp MA, Zhu L. Upregulation of alpha 9 integrin and tenascin during epithelial regeneration after debridement in the cornea. J Histochem Cytochem 1997; 45:189-201.
16. Li Z, Burns AR, Smith CW. Lymphocyte function-associated antigen-1-dependent inhibition of corneal wound healing. Am J Pathol 2006; 169:1590-600.
17. Grenier A, Chollet-Martin S, Crestani B, Delarche C, El Benna J, Boutten A, Andrieu V, Durand G, Gougerot-Pocidalo MA, Aubier M, Dehoux M. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 2002; 99:2997-3004.
18. Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res 1998; 290:S12-23.
19. Ye HQ, Azar DT. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest Ophthalmol Vis Sci 1998; 39:913-21.
20. Sivak JM, Mohan R, Rinehart WB, Xu PX, Maas RL, Fini ME. Pax-6 expression and activity are induced in the reepithelializing cornea and control activity of the transcriptional promoter for matrix metalloproteinase gelatinase B. Dev Biol 2000; 222:41-54.
21. Koo L, Chang HC, Leu TH, Maa MC, Hung WC. Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway. J Cell Physiol 2006; 207:729-34.
22. Sato H, Kita M, Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to rednoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem 1993; 268:23460-8.
23. Lee CW, Lin CC, Lin WN, Liang KC, Luo SF, Wu CB, Wang SW, Yang CM. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/ PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007; 292:L799-812.